Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-55072-6
- By:
- Publication type:
- Article
Works by Chen, Kepan
Results: 6
1
2
A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma.
- Published in:
- Nano Research, 2023, v. 16, n. 4, p. 5357, doi. 10.1007/s12274-022-5254-x
- By:
- Publication type:
- Article
3
mRNA-based therapeutics: powerful and versatile tools to combat diseases.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01007-w
- By:
- Publication type:
- Article
4
MHCI trafficking signal‐based mRNA vaccines strengthening immune protection against RNA viruses.
- Published in:
- Bioengineering & Translational Medicine, 2025, v. 10, n. 1, p. 1, doi. 10.1002/btm2.10709
- By:
- Publication type:
- Article
5
Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors.
- Published in:
- Advanced Science, 2023, v. 10, n. 3, p. 1, doi. 10.1002/advs.202205532
- By:
- Publication type:
- Article
6
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 39, p. 1, doi. 10.1002/adfm.202204692
- By:
- Publication type:
- Article